Concepedia

Lorenza Wyder

LW

Statistics

Publications

13

Citations

1.7K

H-Index

13

Active since

2000

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Actelion (Switzerland)

University Hospital of Zurich

Lorenza Wyder is an author at Novartis (Switzerland) specializing in medicine, cell signaling, and angiogenesis.

Publications per year

2000–2014

13

Publications

13

Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

Louise E. Reynolds, Lorenza Wyder, Julie C. Lively et al. · Nature Medicine · 2002 · 610 citations

, , +15

Antagonism of Sphingosine-1-Phosphate Receptors by FTY720 Inhibits Angiogenesis and Tumor Vascularization

Kenneth R. LaMontagne, Amanda Littlewood‐Evans, Christian Schnell et al. · Cancer Research · 2006 · 298 citations

, , +17

Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent

Rita Andraos, Zhiyan Qian, Débora Bonenfant et al. · Cancer Discovery · 2012 · 130 citations · Full text

, , +17

Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805

Fabienne Baffert, Catherine H. Régnier, Alain De Pover et al. · Molecular Cancer Therapeutics · 2010 · 120 citations

, , +13

Reduced pathological angiogenesis and tumor growth in mice lacking GPR4, a proton sensing receptor

Lorenza Wyder, Thomas Suply, Bérangère Ricoux et al. · Angiogenesis · 2011 · 94 citations

, , +13

1–5 of 13